References
- Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global Cancer Statistics 2018 : GLOBOCAN Estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:https://doi.org/10.3322/caac.21492
- Koh W-J, Abu-Rustum NR, Bean S, Bradley K, Campos SM, Cho KR, Chon HS, Chu C, Clark R, Cohn D, et al. Cervical Cancer, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2019;17(1):64–84. doi:https://doi.org/10.6004/jnccn.2019.0001. 30659131.
- Dracham CB, Mahajan R, Rai B, Elangovan A, Bhattacharya T, Ghoshal S. Toxicity and clinical outcomes with definitive three-dimensional conformal radiotherapy (3DCRT) and concurrent cisplatin chemotherapy in locally advanced cervical carcinoma. Jpn J Clin Oncol. 2019;49(2):146–52. doi:https://doi.org/10.1093/jjco/hyy164
- Barret M, Antoun S, Dalban C, Malka D, Mansourbakht T, Zaanan A, Latko E, Taieb J. Sarcopenia is linked to treatment toxicity in patients with metastatic colorectal cancer. Nutr Cancer. 2014; 66(4):583–9.
- Antoun S, Borget I, Lanoy E. Impact of sarcopenia on the prognosis and treatment toxicities in patients diagnosed with cancer. Curr Opin Support Palliat Care. 2013;7(4):383–9. doi:https://doi.org/10.1097/SPC.0000000000000011
- Arrieta O, Michel Ortega RM, Villanueva-Rodríguez G, Serna-Thomé MG, Flores-Estrada D, Diaz-Romero C, Rodríguez CM, Martínez L, Sánchez-Lara K. Association of nutritional status and serum albumin levels with development of toxicity in patients with advanced non-small cell lung cancer treated with paclitaxel-cisplatin chemotherapy: A prospective study. BMC Cancer. 2010;10(1):7. doi:https://doi.org/10.1186/1471-2407-10-50
- Prado CMM, Baracos VE, McCargar LJ, Mourtzakis M, Mulder KE, Reiman T, Butts CA, Scarfe AG, Sawyer MB. Body composition as an independent determinant of 5-fluorouracil-based chemotherapy toxicity. Clin Cancer Res. 2007;13(11):3264–8.
- Antoun S, Baracos VE, Birdsell L, Escudier B, Sawyer MB. Low body mass index and sarcopenia associated with dose-limiting toxicity of sorafenib in patients with renal cell carcinoma. Ann Oncol. 2010;21(8):1594–8. doi:https://doi.org/10.1093/annonc/mdp605
- Jaffrin MY, Morel H. Body fluid volumes measurements by impedance: A review of bioimpedance spectroscopy (BIS) and bioimpedance analysis (BIA) methods. Med Eng Phys. 2008;30(10):1257–69. doi:https://doi.org/10.1016/j.medengphy.2008.06.009
- Norman K, Stobäus N, Zocher D, Bosy-Westphal A, Szramek A, Scheufele R, Smoliner C, Pirlich M. Cutoff percentiles of bioelectrical phase angle predict functionality, quality of life, and mortality in patients with cancer 1. Am J Clin Nutr. 2010;92:612–9. doi:https://doi.org/10.3945/ajcn.2010.29215
- Lee J, Chang C-L, Lin J-B, Wu M-H, Sun F-J, Wu C-J, Tai H-C, Hsu S-M, Chen Y-J. The effect of body mass index and weight change on late gastrointestinal toxicity in locally advanced cervical cancer treated with intensity-modulated radiotherapy. Int J Gynecol Cancer. 2018;28(7):1377–86. doi:https://doi.org/10.1097/IGC.0000000000001312
- Rubinsak LA, Kang L, Fields EC, Carter JS, McGuire WP, Temkin SM. Treatment-related radiation toxicity among cervical cancer patients. Int J Gynecol Cancer. 2018;28(7):1387–93. doi:https://doi.org/10.1097/IGC.0000000000001309
- Segura A, Pardo J, Jara C, Zugazabeitia L, Carulla J, de Las Peñas R, García-Cabrera E, Luz Azuara M, Casadó J, Gómez-Candela C. An epidemiological evaluation of the prevalence of malnutrition in Spanish patients with locally advanced or metastatic cancer. Clin Nutr. 2005;24(5):801–14. doi:https://doi.org/10.1016/j.clnu.2005.05.001
- Espinosa-Cuevas M de los Á, Rivas-Rodríguez L, González-Medina EC, Atilano-Carsi X, Miranda-Alatriste P, Correa-Rotter R. Vectores de impedancia bioeléctrica para la composición corporal en población mexicana. Rev Investig Clin. 2007; 59(1):15–24.
- Piccoli A. Bioelectric impedance measurement for fluid status assessment. Fluid Overload. 2010;164:143–52.
- Sergi G, De Rui M, Veronese N, Bolzetta F, Berton L, Carraro S, Bano G, Coin A, Manzato E, Perissinotto E. Assessing appendicular skeletal muscle mass with bioelectrical impedance analysis in free-living Caucasian older adults. Clin Nutr. 2015;34(4):667–73. doi:https://doi.org/10.1016/j.clnu.2014.07.010
- Janssen I, Heymsfield SB, Baumgartner RN, Ross R. Estimation of skeletal muscle mass by bioelectrical impedance analysis. J Appl Physiol (1985)). 2000;89(2):465–71. doi:https://doi.org/10.1152/jappl.2000.89.2.465
- Jentoft AJC, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F. Sarcopenia : consenso europeo sobre su definición y diagnóstico Informe del Grupo europeo de trabajo sobre la sarcopenia en personas de edad avanzada. Age Ageing. 2010;44:412–23.
- Kim GR, Sun J, Han M, Park S, Nam CM. Impact of handgrip strength on cardiovascular, cancer and all-cause mortality in the Korean longitudinal study of ageing. BMJ Open. 2019;9(5):e027019. doi:https://doi.org/10.1136/bmjopen-2018-027019
- Prado CMM, Baracos VE, McCargar LJ, Reiman T, Mourtzakis M, Tonkin K, Mackey JR, Koski S, Pituskin E, Sawyer MB, et al. Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatment. Clin Cancer Res. 2009;15(8):2920–6.
- Jung H-W, Kim JW, Kim J-Y, Kim S-W, Yang HK, Lee JW, Lee K-W, Kim D-W, Kang S-B, Kim K-i, et al. Effect of muscle mass on toxicity and survival in patients with colon cancer undergoing adjuvant chemotherapy. Support Care Cancer. 2015;23(3):687–94. doi:https://doi.org/10.1007/s00520-014-2418-6
- Ali R, Baracos VE, Sawyer MB, Bianchi L, Roberts S, Assenat E, Mollevi C, Senesse P. Lean body mass as an independent determinant of dose-limiting toxicity and neuropathy in patients with colon cancer treated with FOLFOX regimens. Cancer Med. 2016;5(4):607–16. doi:https://doi.org/10.1002/cam4.621
- Aleixo GFP, Williams GR, Nyrop KA, Muss HB, Shachar SS. Muscle composition and outcomes in patients with breast cancer: meta-analysis and systematic review. Breast Cancer Res Treat. 2019;177(3):569–11. doi:https://doi.org/10.1007/s10549-019-05352-3
- Dev R . Measuring cachexia-diagnostic criteria. Ann Palliat Med. 2019;8(1):24–32. doi:https://doi.org/10.21037/apm.2018.08.07
- Aust S, Knogler T, Pils D, Obermayr E, Reinthaller A, Zahn L, Radlgruber I, Mayerhoefer ME, Grimm C, Polterauer S, et al. Skeletal muscle depletion and markers for cancer cachexia are strong prognostic factors in epithelial ovarian cancer. PLoS One. 2015;10(10):e0140403–13. doi:https://doi.org/10.1371/journal.pone.0140403
- Kroenke CH, Prado CM, Meyerhardt JA, Weltzien EK, Xiao J, Cespedes Feliciano EM, Caan BJ. Muscle radiodensity and mortality in patients with colorectal cancer. Cancer. 2018;124(14):3008–15. doi:https://doi.org/10.1002/cncr.31405
- Martin L, Birdsell L, MacDonald N, Reiman T, Clandinin MT, McCargar LJ, Murphy R, Ghosh S, Sawyer MB, Baracos VE, et al. Cancer cachexia in the age of obesity: Skeletal muscle depletion is a powerful prognostic factor, independent of body mass index. JCO. 2013;31(12):1539–47. doi:https://doi.org/10.1200/JCO.2012.45.2722
- Baracos VE, Reiman T, Mourtzakis M, Gioulbasanis I, Antoun S. Body composition in patients with non-small cell lung cancer: A contemporary view of cancer cachexia with the use of computed tomography image analysis. Am J Clin Nutr. 2010;91(4):1133S–7S. doi:https://doi.org/10.3945/ajcn.2010.28608C
- Gordon JN, Green SR, Goggin PM. Cancer cachexia. QJM. 2005;98(11):779–88. doi:https://doi.org/10.1093/qjmed/hci127
- Jensen GL, Compher C, Sullivan DH, Mullin GE. Recognizing malnutrition in adults: Definitions and characteristics, screening, assessment, and team approach. JPEN J Parenter Enteral Nutr. 2013;37(6):802–7. doi:https://doi.org/10.1177/0148607113492338
- Arends J, Baracos V, Bertz H, Bozzetti F, Calder PC, Deutz NEP, Erickson N, Laviano A, Lisanti MP, Lobo DN, et al. ESPEN expert group recommendations for action against cancer-related malnutrition. Clin Nutr. 2017;36(5):1187–96. doi:https://doi.org/10.1016/j.clnu.2017.06.017
- Croisier E, Brown T, Bauer J. The efficacy of dietary fiber in managing gastrointestinal toxicity symptoms in patients with gynecologic cancers undergoing pelvic radiotherapy: a systematic review. J Acad Nutr Diet. 2020.
- Aredes MA, Garcez MR, Chaves GV. Influence of chemoradiotherapy on nutritional status, functional capacity, quality of life and toxicity of treatment for patients with cervical cancer. Nutr Diet. 2018;75(3):263–70. doi:https://doi.org/10.1111/1747-0080.12414
- Schwenk A, Ward LC, Elia M, Scott GM. Bioelectrical impedance analysis predicts outcome in patients with suspected bacteremia. Infection. 1998;26(5):277–82. doi:https://doi.org/10.1007/BF02962247
- Gupta D, Lammersfeld CA, Burrows JL, Dahlk SL, Vashi PG, Grutsch JF, Hoffman S, Lis CG. Bioelectrical impedance phase angle in clinical practice: Implications for prognosis in advanced colorectal cancer. Am J Clin Nutr. 2004;80(6):1634–8. doi:https://doi.org/10.1093/ajcn/80.6.1634
- Gupta D, Lis CG, Dahlk SL, Vashi PG, Grutsch JF, Lammersfeld CA. Bioelectrical impedance phase angle as a prognostic indicator in advanced pancreatic cancer. Br J Nutr. 2004;92(6):957–62. doi:https://doi.org/10.1079/BJN20041292
- Toso S, Piccoli A, Gusella M, Menon D, Crepaldi G, Bononi A, Ferrazzi E. Bioimpedance vector pattern in cancer patients without disease versus locally advanced or disseminated disease. Nutrition. 2003;19(6):510–4. doi:https://doi.org/10.1016/S0899-9007(02)01084-5